Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2005 7(4):476-484; DOI:10.1215/S1152851704000754
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heese, O.
Right arrow Articles by Lamszus, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Basic and Translational Investigations

Neural stem cell migration toward gliomas in vitro

Oliver Heese1, Andreas Disko, Dorothea Zirkel, Manfred Westphal and Katrin Lamszus

Department of Neurosurgery, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany

1 Address correspondence to Oliver Heese, Department of Neurosurgery, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany (heese{at}uke.uni-hamburg.de).

Abstract

Various in vivo studies demonstrated a migration tendency of neural stem cells (NSCs) toward gliomas, making these cells a potential carrier for delivery of therapeutic genes to disseminated glioma cells. We analyzed which factors determine NSC migration and invasion in vitro. Conditioned media prepared from 10 different human glioma cell lines, as well as 13 different tumor-associated growth factors, were analyzed for their chemotactic effects on murine C17.2 NSCs. The growth factor receptor status was analyzed by reverse transcriptase-polymerase chain reaction. Invasion of NSCs into multicellular tumor spheroids generated from 10 glioma cell lines was quantified. NSCs displayed a heterogeneous migration pattern toward glioma spheroids as well as toward glioma-cell-conditioned medium. Chemotactic migration was stimulated up to fivefold by conditioned medium as compared to controls. In coculture assays, NSC invasion varied from single cell invasion into glioma spheroids to complete dissemination of NSCs into glioma spheroids of different cell lines. Among 13 different growth factors, scatter factor/hepatocyte growth factor (SF/HGF) was the most powerful chemoattractant for NSCs, inducing a 2.5-fold migration stimulation. An antibody against SF/HGF inhibited migratory stimulation induced by conditioned media. NSC migration can be stimulated by various growth factors, similar to glioma cell migration. The extent to which NSCs infiltrate three-dimensional glioma cell aggregates appears to depend on additional factors, which are likely to include cell-to-cell contacts and interaction with extracellular matrix proteins.




This article has been cited by other articles:


Home page
Stem CellsHome page
S. E. Kendall, J. Najbauer, H. F. Johnston, M. Z. Metz, S. Li, M. Bowers, E. Garcia, S. U. Kim, M. E. Barish, K. S. Aboody, et al.
Neural Stem Cell Targeting of Glioma Is Dependent on Phosphoinositide 3-Kinase Signaling
Stem Cells, June 1, 2008; 26(6): 1575 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Gutova, J. Najbauer, R. T. Frank, S. E. Kendall, A. Gevorgyan, M. Z. Metz, M. Guevorkian, M. Edmiston, D. Zhao, C. A. Glackin, et al.
Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Mediate Human Stem Cell Tropism to Malignant Solid Tumors
Stem Cells, June 1, 2008; 26(6): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. B. Hoelzinger, T. Demuth, and M. E. Berens
Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
J Natl Cancer Inst, November 7, 2007; 99(21): 1583 - 1593.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2005 by Society for Neuro-Oncology